{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T04:54:52Z","timestamp":1776228892767,"version":"3.50.1"},"reference-count":86,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T00:00:00Z","timestamp":1769299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Imam Abdulrahman Bin Faisal University, Dammam"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Erythropoiesis is a tightly regulated developmental process that requires the switch from fetal hemoglobin (HbF) to adult hemoglobin (HbA). In \u03b2-hemoglobinpathies such as SCD and \u03b2-thalassemia, disease severity is influenced by the fetal-to-adult hemoglobin switch because persistence or induction of HbF will ameliorate the clinical manifestations. miRNAs play an essential role in regulating this switch by modulating the expression levels of key transcription factors, such as BCL11A, KLF1, and MYB, which repress \u03b3-globin expression. Multiple miRNAs have been identified as potential modulators of the hemoglobin switch, including miR-144, miR-486, miR-26b, and miR-15a. The molecular interactions between miRNA and \u03b3-to \u03b2-globin switch have the potential for new therapeutic interventions that aim to reactivate HbF expression to ameliorate \u03b2-hemoglobinopathies such as SCD and \u03b2-thalassemia. In this review, the latest advancements in miRNA-mediated regulation of Hb switching and nanoparticle-based strategies for miRNA delivery are explored.<\/jats:p>","DOI":"10.3390\/ijms27031203","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T08:14:23Z","timestamp":1769415263000},"page":"1203","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["miRNA-Mediated Regulation of \u03b3-Globin to \u03b2-Globin Switching: Therapeutic Potential in \u03b2-Hemoglobinopathies"],"prefix":"10.3390","volume":"27","author":[{"given":"Daniah","family":"Alotaibi","sequence":"first","affiliation":[{"name":"College of Medicine, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Falak","family":"Aldagdog","sequence":"additional","affiliation":[{"name":"College of Medicine, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sajidah","family":"Alramadhan","sequence":"additional","affiliation":[{"name":"College of Medicine, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basmah","family":"Almuhaidib","sequence":"additional","affiliation":[{"name":"College of Medicine, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nada","family":"Asiri","sequence":"additional","affiliation":[{"name":"College of Medicine, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leena","family":"Almodhi","sequence":"additional","affiliation":[{"name":"College of Medicine, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manar","family":"Alshabaan","sequence":"additional","affiliation":[{"name":"College of Medicine, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Razan","family":"Alborhan","sequence":"additional","affiliation":[{"name":"School of Medicine, University College Dublin, Belfield, Dublin 4, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3026-5520","authenticated-orcid":false,"given":"Chittibabu","family":"Vatte","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, College of Medicine, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1007-1534","authenticated-orcid":false,"given":"Shamim Shaikh","family":"Mohiuddin","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, College of Medicine, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0673-3534","authenticated-orcid":false,"given":"Amein K.","family":"Alali","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, College of Medicine, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5384-8764","authenticated-orcid":false,"given":"Alawi","family":"Habara","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, College of Medicine, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1177\/1535370216636726","article-title":"Minireview: Genetic basis of heterogeneity and severity in sickle cell disease","volume":"241","author":"Habara","year":"2016","journal-title":"Exp. Biol. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/S0140-6736(15)01341-0","article-title":"Fetal haemoglobin in sickle-cell disease: From genetic epidemiology to new therapeutic strategies","volume":"387","author":"Lettre","year":"2016","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/ajh.24872","article-title":"Fetal hemoglobin in sickle cell anemia: The Arab-Indian haplotype and new therapeutic agents","volume":"92","author":"Habara","year":"2017","journal-title":"Am. J. Hematol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/s41467-025-56578-3","article-title":"Base editing HbS to HbG-Makassar improves hemoglobin function supporting its use in sickle cell disease","volume":"16","author":"Kostamo","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00277-025-06216-1","article-title":"A review on disease modifying pharmacologic therapies for sickle cell disease","volume":"104","author":"Mahadevia","year":"2025","journal-title":"Ann. Hematol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3390\/hearts5020016","article-title":"The impact of sickle cell disease on acute coronary syndrome and PCI outcomes: A retrospective observational study","volume":"5","author":"Alharbi","year":"2024","journal-title":"Hearts"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.abb.2012.01.001","article-title":"Hb S-S\u00e3o Paulo: A new sickling hemoglobin with stable polymers and decreased oxygen affinity","volume":"519","author":"Jorge","year":"2012","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa040771","article-title":"Hemoglobin Jamaica Plain\u2014A sickling hemoglobin with reduced oxygen affinity","volume":"351","author":"Geva","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_9","first-page":"4375","article-title":"HbS-oman heterozygote: A new dominant sickle syndrome","volume":"92","author":"Nagel","year":"1998","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Vellanki, S., Thalambedu, N., Kumar, A.K.T.A., Vellanki, S., Honhar, M., Hendrix, R., Harris, D., Gaddam, M., Singh, S.R., and Jain, S. (2025). Navigating Hyperhemolysis in Sickle Cell Disease: Insights from Literature. Diagnostics, 15.","DOI":"10.3390\/diagnostics15141835"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1100\/tsw.2008.157","article-title":"Sickle cell anemia, the first molecular disease: Overview of molecular etiology, pathophysiology, and therapeutic approaches","volume":"8","author":"Steinberg","year":"2008","journal-title":"Sci. World J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"18010","DOI":"10.1038\/nrdp.2018.10","article-title":"Sickle cell disease","volume":"4","author":"Kato","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.ajpath.2018.12.012","article-title":"Ischemia-reperfusion injury in sickle cell disease: From basics to therapeutics","volume":"189","author":"Ansari","year":"2019","journal-title":"Am. J. Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1172\/JCI133639","article-title":"The multifaceted role of ischemia\/reperfusion in sickle cell anemia","volume":"130","author":"Hebbel","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41573-018-0003-2","article-title":"Therapeutic strategies for sickle cell disease: Towards a multi-agent approach","volume":"18","author":"Telen","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(17)31822-6","article-title":"Thalassaemia","volume":"391","author":"Taher","year":"2018","journal-title":"Lancet"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMra2021838","article-title":"\u03b2-Thalassemias","volume":"384","author":"Taher","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1080\/03630269.2025.2567265","article-title":"Hemoglobin Dieppe (HBB: C. 383A > G): A Rare Dominant \u03b2-Thalassemia in an Iraqi Kurdish Family","volume":"49","author":"Osman","year":"2025","journal-title":"Hemoglobin"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/ncb0309-228","article-title":"Many roads to maturity: microRNA biogenesis pathways and their regulation","volume":"11","author":"Winter","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41576-023-00611-y","article-title":"microRNAs in action: Biogenesis, function and regulation","volume":"24","author":"Shang","year":"2023","journal-title":"Nat. Rev. Genet."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2029392","article-title":"Post-transcriptional genetic silencing of BCL11A to treat sickle cell disease","volume":"384","author":"Esrick","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Gasparello, J., Fabbri, E., Bianchi, N., Breveglieri, G., Zuccato, C., Borgatti, M., Gambari, R., and Finotti, A. (2017). BCL11A mRNA targeting by miR-210: A possible network regulating \u03b3-globin gene expression. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18122530"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1007\/s11033-020-05483-7","article-title":"miR-30a regulates \u03b3-globin expression in erythoid precursors of intermedia thalassemia through targeting BCL11A","volume":"47","author":"Gholampour","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.exphem.2018.03.004","article-title":"miR-326 regulates HbF synthesis by targeting EKLF in human erythroid cells","volume":"63","author":"Li","year":"2018","journal-title":"Exp. Hematol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13148-025-01962-5","article-title":"Comprehensive regulation of \u03b3-globin expression by epigenetic modifications and protein post-translational modifications","volume":"17","author":"Ye","year":"2025","journal-title":"Clin. Epigenet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1177\/15353702211028195","article-title":"Exploring epigenetic and microRNA approaches for \u03b3-globin gene regulation","volume":"246","author":"Fitzgerald","year":"2021","journal-title":"Exp. Biol. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00277-020-04390-y","article-title":"Erythrocyte microRNAs: A tiny magic bullet with great potential for sickle cell disease therapy","volume":"100","author":"Verma","year":"2021","journal-title":"Ann. Hematol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Habara, A. (2025). Comparative circRNA Profiling in Human Erythroblasts Derived from Fetal Liver and Bone Marrow Hematopoietic Stem Cells Using Public RNA-Seq Data. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26178397"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"BSR20190604","DOI":"10.1042\/BSR20190604","article-title":"BCL11A: A potential diagnostic biomarker and therapeutic target in human diseases","volume":"39","author":"Yin","year":"2019","journal-title":"Biosci. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.bcmd.2008.06.007","article-title":"BCL11A is a major HbF quantitative trait locus in three different populations with \u03b2-hemoglobinopathies","volume":"41","author":"Sedgewick","year":"2008","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s40291-022-00589-z","article-title":"Targeting genetic modifiers of HBG gene expression in sickle cell disease: The miRNA option","volume":"26","author":"Gu","year":"2022","journal-title":"Mol. Diagn. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1126\/science.1242088","article-title":"An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level","volume":"342","author":"Bauer","year":"2013","journal-title":"Science"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1126\/science.1165409","article-title":"Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A","volume":"322","author":"Sankaran","year":"2008","journal-title":"Science"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41588-019-0568-7","article-title":"Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation","volume":"52","author":"Basak","year":"2020","journal-title":"Nat. Genet."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1182\/blood-2024-203712","article-title":"Association of LRF with MBD3-NuRD Versus MBD2 NuRD Mediates Opposing Effects on Developmental Globin Gene Regulation","volume":"144","author":"Shang","year":"2024","journal-title":"Blood"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.ymthe.2024.01.023","article-title":"Base editing of key residues in the BCL11A-XL-specific zinc finger domains derepresses fetal globin expression","volume":"32","author":"Rajendiran","year":"2024","journal-title":"Mol. Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"493","DOI":"10.5483\/BMBRep.2009.42.8.493","article-title":"Expression of miR-210 during erythroid differentiation and induction of \u03b3-globin gene expression","volume":"42","author":"Bianchi","year":"2009","journal-title":"BMB Rep."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Lulli, V., Romania, P., Morsilli, O., Cianciulli, P., Gabbianelli, M., Testa, U., Giuliani, A., and Marziali, G. (2013). MicroRNA-486-3p regulates \u03b3-globin expression in human erythroid cells by directly modulating BCL11A. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0060436"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e00351","DOI":"10.1042\/BSR20160023","article-title":"MicroRNA 486-3P as a stability marker in acute coronary syndrome","volume":"36","author":"Wei","year":"2016","journal-title":"Biosci. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Chen, M., Wang, X., Wang, H., Zhang, M., Chen, L., Chen, H., Pan, Y., Zhang, Y., Xu, L., and Huang, H. (2023). The clinical value of hsa-miR-190b-5p in peripheral blood of pediatric \u03b2-thalassemia and its regulation on BCL11A expression. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0292031"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3892\/mmr.2024.13372","article-title":"Upregulation of miR-6747-3p affects red blood cell lineage development and induces fetal hemoglobin expression by targeting BCL11A in \u03b2-thalassemia","volume":"31","author":"Lv","year":"2024","journal-title":"Mol. Med. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/hmg\/ddae180","article-title":"The role of miR-129-5p in regulating \u03b3-globin expression and erythropoiesis in \u03b2-thalassemia","volume":"34","author":"Li","year":"2025","journal-title":"Hum. Mol. Genet."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s13023-025-03806-0","article-title":"Upregulation of miR-17-3p is associated with HbF in patients with \u03b2-thalassemia and induces \u03b3-globin expression by targeting BCL11A","volume":"20","author":"Zhang","year":"2025","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1182\/bloodadvances.2016002303","article-title":"KLF1 directly activates expression of the novel fetal globin repressor ZBTB7A\/LRF in erythroid cells","volume":"1","author":"Norton","year":"2017","journal-title":"Blood Adv."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/ng.637","article-title":"KLF1 regulates BCL11A expression and \u03b3-to \u03b2-globin gene switching","volume":"42","author":"Zhou","year":"2010","journal-title":"Nat. Genet."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nm.3814","article-title":"Anemia: Progress in molecular mechanisms and therapies","volume":"21","author":"Sankaran","year":"2015","journal-title":"Nat. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40169-016-0092-7","article-title":"Hydroxyurea down-regulates BCL11A, KLF-1 and MYB through miRNA-mediated actions to induce \u03b3-globin expression: Implications for new therapeutic approaches of sickle cell disease","volume":"5","author":"Pule","year":"2016","journal-title":"Clin. Transl. Med."},{"key":"ref_48","first-page":"53","article-title":"Evaluation of the effect of miR-26b up-regulation on HbF expression in erythroleukemic K-562 cell line","volume":"6","author":"Alijani","year":"2014","journal-title":"Avicenna J. Med. Biotechnol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1073\/pnas.1018384108","article-title":"MicroRNA-15a and-16-1 act via MYB to elevate fetal hemoglobin expression in human trisomy 13","volume":"108","author":"Sankaran","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/bjh.15870","article-title":"MIR 29B mediates epigenetic mechanisms of HBG gene activation","volume":"186","author":"Smith","year":"2019","journal-title":"Br. J. Haematol."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Gu, Q., Palani, C.D., Smith, A., Li, B., Amos-Abanyie, E.K., Ogu, U., Lu, L., Pace, B.S., and Starlard-Davenport, A. (2022). MicroRNA29B induces fetal hemoglobin via inhibition of the HBG repressor protein MYB in vitro and in humanized sickle cell mice. Front. Med., 9.","DOI":"10.3389\/fmed.2022.1043686"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0378-1119(01)00346-8","article-title":"Cloning, characterization and chromosome mapping of the human SOX6 gene","volume":"265","author":"Hagiwara","year":"2001","journal-title":"Gene"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1101\/gad.1897310","article-title":"Transcriptional silencing of \u03b3-globin by BCL11A involves long-range interactions and cooperation with SOX6","volume":"24","author":"Xu","year":"2010","journal-title":"Genes Dev."},{"key":"ref_54","first-page":"3669","article-title":"Sox6 enhances erythroid differentiation in human erythroid progenitors","volume":"117","author":"Ierardi","year":"2011","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"9496058","DOI":"10.1155\/2017\/9496058","article-title":"SOX6 Downregulation Induces \u03b3-Globin in Human \u03b2-Thalassemia Major Erythroid Cells","volume":"2017","author":"Li","year":"2017","journal-title":"BioMed Res. Int."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"9357","DOI":"10.1002\/jcb.27253","article-title":"Disruption of SOX6 gene using CRISPR\/Cas9 technology for gamma-globin reactivation: An approach towards gene therapy of \u03b2-thalassemia","volume":"119","author":"Shariati","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"102025","DOI":"10.1016\/j.omtn.2023.09.002","article-title":"miR-365-3p mediates BCL11A and SOX6 erythroid-specific coregulation: A new player in HbF activation","volume":"34","author":"Simbula","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"8071","DOI":"10.1038\/s41598-022-12002-0","article-title":"Analysis of circRNAs and circRNA-associated competing endogenous RNA networks in \u03b2-thalassemia","volume":"12","author":"Yang","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"9896","DOI":"10.1073\/pnas.0502041102","article-title":"The binding of the ubiquitous transcription factor Sp1 at the locus control region represses the expression of \u03b2-like globin genes","volume":"102","author":"Feng","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1128\/MCB.00623-13","article-title":"A feedback loop consisting of microRNA 23a\/27a and the \u03b2-like globin suppressors KLF3 and SP1 regulates globin gene expression","volume":"33","author":"Ma","year":"2013","journal-title":"Mol. Cell. Biol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Azzouzi, I., Moest, H., Winkler, J., Fauch\u00e8re, J.-C., Gerber, A.P., Wollscheid, B., Stoffel, M., Schmugge, M., and Speer, O. (2011). MicroRNA-96 directly inhibits \u03b3-globin expression in human erythropoiesis. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0022838"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"9883","DOI":"10.1038\/s41598-018-28118-1","article-title":"Circulating miR-30a-5p as a prognostic biomarker of left ventricular dysfunction after acute myocardial infarction","volume":"8","author":"Maciejak","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1111\/jcmm.13278","article-title":"Micro RNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy","volume":"21","author":"Chen","year":"2017","journal-title":"J. Cell. Mol. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1002\/hep.31221","article-title":"miR-210 participates in hepatic ischemia reperfusion injury by forming a negative feedback loop with SMAD4","volume":"72","author":"Pan","year":"2020","journal-title":"Hepatology"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Arul, J.C., Raja Beem, S.S., Parthasarathy, M., Kuppusamy, M.K., Rajamani, K., and Silambanan, S. (2025). Association of microRNA-210-3p with NT-proBNP, sST2, and Galectin-3 in heart failure patients with preserved and reduced ejection fraction: A cross-sectional study. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0320365"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/kjm2.12211","article-title":"MiR-129-5p alleviates myocardial injury by targeting suppressor of cytokine signaling 2 after ischemia\/reperfusion","volume":"36","author":"Ma","year":"2020","journal-title":"Kaohsiung J. Med. Sci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2785113","DOI":"10.1155\/2022\/2785113","article-title":"Exosomal miR-17-3p Alleviates Programmed Necrosis in Cardiac Ischemia\/Reperfusion Injury by Regulating TIMP3 Expression","volume":"2022","author":"Liu","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.7150\/thno.67722","article-title":"G\u03b112 overexpression in hepatocytes by ER stress exacerbates acute liver injury via ROCK1-mediated miR-15a and ALOX12 dysregulation","volume":"12","author":"Tak","year":"2022","journal-title":"Theranostics"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1016\/j.ymthe.2022.05.002","article-title":"Development of a double shmiR lentivirus effectively targeting both BCL11A and ZNF410 for enhanced induction of fetal hemoglobin to treat \u03b2-hemoglobinopathies","volume":"30","author":"Liu","year":"2022","journal-title":"Mol. Ther."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"101254","DOI":"10.1016\/j.omtm.2024.101254","article-title":"A novel high-titer, bifunctional lentiviral vector for autologous hematopoietic stem cell gene therapy of sickle cell disease","volume":"32","author":"Hart","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jcyt.2024.11.006","article-title":"Gene Therapy for Sickle Cell Disease: Recent Advances, Clinical Trials, and Future directions","volume":"27","author":"Ballantine","year":"2024","journal-title":"Cytotherapy"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.omtm.2020.03.015","article-title":"Preclinical evaluation of a novel lentiviral vector driving lineage-specific BCL11A knockdown for sickle cell gene therapy","volume":"17","author":"Brendel","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1111\/bjh.20107","article-title":"Cholesterol-conjugated miR-29b induces fetal haemoglobin expression via \u03b3-globin promoter demethylation in the Townes mouse model for sickle cell anaemia","volume":"206","author":"Palani","year":"2025","journal-title":"Br. J. Haematol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.cell.2018.03.016","article-title":"Direct promoter repression by BCL11A controls the fetal to adult hemoglobin switch","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1172\/JCI71520","article-title":"HBS1L-MYB intergenic variants modulate fetal hemoglobin via long-range MYB enhancers","volume":"124","author":"Stadhouders","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Guido, C., Maiorano, G., Guti\u00e9rrez-Mill\u00e1n, C., Cortese, B., Trapani, A., D\u2019Amone, S., Gigli, G., and Palam\u00e0, I.E. (2021). Erythrocytes and nanoparticles: New therapeutic systems. Appl. Sci., 11.","DOI":"10.3390\/app11052173"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s11095-016-1864-x","article-title":"Nanoparticle Attachment to Erythrocyte Via the Glycophorin A Targeted ERY1 Ligand Enhances Binding without Impacting Cellular Function","volume":"33","author":"Sahoo","year":"2016","journal-title":"Pharm. Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s12276-025-01436-x","article-title":"Transferrin receptors","volume":"57","author":"Guo","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1021\/acs.nanolett.3c00304","article-title":"In vivo RNA delivery to hematopoietic stem and progenitor cells via targeted lipid nanoparticles","volume":"23","author":"Shi","year":"2023","journal-title":"Nano Lett."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1080\/17474086.2024.2429605","article-title":"Crispr-based gene therapy for the induction of fetal hemoglobin in sickle cell disease","volume":"17","author":"McManus","year":"2024","journal-title":"Expert Rev. Hematol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 gene editing for sickle cell disease and \u03b2-thalassemia","volume":"384","author":"Frangoul","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e2400783121","DOI":"10.1073\/pnas.2400783121","article-title":"In utero delivery of targeted ionizable lipid nanoparticles facilitates in vivo gene editing of hematopoietic stem cells","volume":"121","author":"Palanki","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"5689","DOI":"10.1038\/s41467-024-50021-9","article-title":"Hematopoietic stem and progenitor cell membrane-coated vesicles for bone marrow-targeted leukaemia drug delivery","volume":"15","author":"Li","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"11333","DOI":"10.1021\/acsnano.5c00388","article-title":"Modular Layer-by-Layer Nanoparticle Platform for Hematopoietic Progenitor and Stem Cell Targeting","volume":"19","author":"Dacoba","year":"2025","journal-title":"ACS Nano"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1182\/blood-2023-185007","article-title":"Non-Viral RNA-Lipid Nanoparticles for High Efficiency Genome Editing of CD34+ Hematopoietic Stem and Progenitor Cells for Advanced Cell and Gene Therapies","volume":"142","author":"Geczy","year":"2023","journal-title":"Blood"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00253-025-13620-0","article-title":"MiRNA-based drugs: Challenges and delivery strategies","volume":"109","author":"Wang","year":"2025","journal-title":"Appl. Microbiol. Biotechnol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/3\/1203\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T08:19:24Z","timestamp":1769415564000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/3\/1203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,25]]},"references-count":86,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["ijms27031203"],"URL":"https:\/\/doi.org\/10.3390\/ijms27031203","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,25]]}}}